Product Development
Why Verve chose base editing over standard CRISPR for its lead CV candidate
Durable pharmacodynamic data in non-human primates sets up Verve’s path to the clinic in 2022
Durable pharmacodynamic data in non-human primates sets up Verve’s path to the clinic in 2022.
Jan 13, 2021 | 1:10 AM GMT
Verve’s non-human primate data makes the case that base editing
